F.A.I.T.H. Announces Industry-Defining Standard to Resolve the Pharmaceutical Replication Crisis Los Angeles, Biotech
Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029 Business, Health, Biotech, Artificial Intelligence, Financial
FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP Business, Medical, Health, Marketing, Media, Biotech, Financial
Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP Business, Medical, Health, Marketing, Media, Biotech, Financial
Medical Experts Highlight the Importance of Second Opinions in Death Investigations Family, Medical, Health, Science, Biotech
Cardiac Stroke Post Treatment , Therapies, Dr.Abhay Kumar Pati, Physician, Author, Hayward, CA USA Biotech
Organic Compound verses inorganic chemically synthesized Food ingredients., Dr.Abhay Kumar Pati, Phd Biotech
TL Foundation Supports Connect's 2026 Cool Companies to Strengthen San Diego's Innovation Economy San Diego, Investment, Technology, Non-profit, Biotech, Innovation
Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI) Los Angeles, Business, Health, Biotech, Financial
Xycota Biosciences Announces Nature Portfolio Publication Supporting Brain Repair Platform Targeting FTD and ALS Beverly Hills, Medical, Technology, Biotech
Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
TL Foundation Supports Connect's 2026 Cool Companies to Strengthen San Diego's Innovation Economy
Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
Xycota Biosciences Announces Nature Portfolio Publication Supporting Brain Repair Platform Targeting FTD and ALS